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Introduction
Recent advances in noninvasive cardiac ima-
ginghave opened new opportunities for detecting
clinically silent coronary artery disease (CAD). Co-
ronary computed tomography angiography (CCTA)
is an excellent example. Many authors stress its
high negative predictive value, making this nonin-
vasive method especially valuable for excluding sig-
nificant coronary lesions in very high-risk asymp-
tomatic persons and in symptomatic subjects with
a low or moderate CAD probability [1]. As the effi-
cacy of CCTA for risk assessment in pre-renal
transplant patients is uncertain, the study of Mao
et al. [2] refers to an important contemporary clin-
ical issue. Seeking a noninvasive method for exclud-
ing CAD in these patients is of great value, since
other noninvasive modalities have been shown to
be neither specific nor sensitive [3]. As silent CAD
confers a higher procedural risk (transplantation)
and increases the risk for post-transplant cardiovas-
cular complications, at present selective invasive
coronary angiography remains the only reliable ap-
proach [4]. However, some key questions should be
addressed for a balanced understanding of the results
of Mao et al. [2] in terms of the applicability of novel
imaging modality in dialyzed end-stage renal disease
patients awaiting renal transplantation.
What do different current guidelines say?
Risk evaluation of cardiovascular outcome in
patients with end-stage renal disease referred for
renal transplantation is a matter of discordant indi-
cations, regarding various guidelines authors’ ex-
pertise in the field of cardiology, nephrology and
radiology.
Recent cardiology guidelines indicate a need to
consider at least two issues: overall CV risk and
surgical risk [5–7]. Regarding the first, symptomatic
status (angina, dyspnea or equivalents) is of utmost
importance in terms of CAD probability estimation.
In asymptomatic subjects, accumulation of at least
four risk factors (including renal impairment) is
considered substantial. Even so, a level of evidence
is usually low (B or C) due to lack of randomized
trials. For instance, a negative recommendation
regarding CCTA (class III) in patients with no signs
or symptoms suggestive of CAD is given on the
basis of experts’ consensus (level of evidence C)
[5, 6]. The second issue relates to the risk associ-
ated with surgical procedures, among which major
vascular surgery is graded the highest [7]. In such
a setting, invasive coronary angiography (ICA) may
be considered (class IIB, level B) [7]. Unfortunate-
ly, cardiology guidelines do not refer specifically to
patients with end-stage renal disease (ESRD) or re-
nal transplant candidates/recipients.
In contrast to cardiologists, nephrologists con-
sider noninvasive methods, albeit constituents of
their opinions, are weaker and conflicting, and they
do not come from randomized trials (class B = ana-
logy to class II for cardiology guidelines) [8]. As the
main fear of nephrologists relates to the use of con-
trasting media for invasive coronary angiography,
many noninvasive methods have been examined
over past decades in a search of the best way of dia-
gnosing CAD and risk prediction in ESRD patients.
In general, only high-risk ESRD patients with pos-
itive cardiac stress test(s) should undergo ICA for
possible revascularization prior to transplantation
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[9]. Also, the risk associated with ICA cannot be
ignored in ESRD patients in general, since only
a low proportion requires revascularization before
renal transplantation in contrast to a relatively high
proportion of patients being at high risk as assessed
noninvasively (class B) [9]. It is worth pointing out
that evidence of significant coronary artery steno-
sis does not necessarily bear a risk for an unfavor-
able cardiovascular outcome, as plaque instability,
rather than angiographic stenotic lesion, is associ-
ated with infarction [9].
Last, but not least, radiologists consider CCTA
only in symptomatic patients to be justified depend-
ing on CAD probability (low or moderate) [10, 11].
Unfortunately, no solutions for ESRD patients, and
for those who are renal-transplant candidates in par-
ticular, are provided. However, the risk associated
with X-ray exposure is considered as one of the major
limiting factors for the wider use of CCTA [12].
Thus, a discrepancy between guidelines leaves
many areas open for researchers. However, weak-
nesses of guidelines should be taken into conside-
ration and should constitute objectives of further
investigations.
Did the study of Mao et al.
answer the questions?
Mao et al. [2] carried out a small, one center,
study in which hypertensive dialyzed ESRD pa-
tients awaiting renal transplantation had a CCTA
examination for CAD exclusion. The authors fo-
cused on feasibility, quality, reproducibility and
safety of CCTA.
The small number of examined subjects is one
of the major limitations of the study. As most pa-
tients were African-American (89%), any generali-
zation for the entire population, or whites only,
should be treated with caution. Additionally, the risk
factors evidenced differ from those usually consi-
dered and indicated by guidelines. For instance,
smoking status was ignored, while studies in nor-
mal and symptomatic populations list smoking as
the most important factor. In addition, CAD proba-
bility based on clinical presentation has been omit-
ted in the study. Being aware of guidelines, symp-
tomatic status plays a crucial role for both indica-
tion for CCTA and its interpretation.
The mean age of examined persons represents
the usual value for patients referred for renal trans-
plantation. However, in this specific subset of pa-
tients, accelerated arterial calcification and its re-
lation to patho-mechanisms somewhat different
from atherosclerotic process, has long been ac-
knowledged. In terms of coronary artery calcium
values (mean 684 ± 1632 Agatston units), the exam-
ined patients can represent 90th percentile strata for
age or can be compared to 70 year-old asymptomatic
subjects. In such cases, the calcium burden has been
shown to limit the reliability of CCTA [5, 13].
In the study of Mao et al. [2] poor quality of
imaging affected almost 40% of analyzed segments
of the coronaries, though only in six patients the
coronary artery calcium had been scored above 400
Agatston units. Importantly, in ten (36%) ESRD
patients with a ‘zero’ coronary artery calcium, there
were no coronary lesions on CCTA. The proportion
of un-interpretable stenoses within main epicardial
coronaries varies depending on readers, achieving
six and ten patients (respectively), which accounts
for 25% and 37% of uncertainties (Table 2 of Mao’s
study). Thus, in every fourth (or every third by
second reader) patient with ESRD, the critical
stenosis, which might be an object of coronary in-
tervention, cannot be reliably assessed. The ques-
tion is whether the glass in this case is seen to be
half-empty or half-full? From a clinical viewpoint,
X-ray exposition and contrast media use would not
be justified if the result can be inconclusive in such
a proportion.
What does the study add?
For the first time, it was shown that in asymp-
tomatic ESRD patients referred for renal transplan-
tation, CCTA is feasible, well tolerated and safe. It
also documented that in this subset of patients,
a ‘zero’ calcium score strongly advocates against the
presence of stenotic atherosclerotic lesions. In ad-
dition, the authors found that complementary non-
invasive evaluation by means of morphometric and
functional methods (dobutamine-stress echocardio-
graphy) might be of value [2].
What does the study fail to answer?
Lack of ICA renders a reliable assessment of
coronaries impossible. Thus, the statistical perfor-
mance of CCTA cannot be judged. As the presence
of significant stenosis within major coronary arter-
ies on CCTA might not necessarily be confirmed
by invasive evaluation, its clinical significance re-
mains unknown [1, 5–7]. Also, a relatively low Kap-
pa statistic at segment level (0.46) indicates a high
dependence of stenosis grading according to the in-
dividual experience of investigators. In other words,
an assessment of coronary lesions seems to be ra-
ther subjective, and in some cases inconclusive. It
329
Maciej Sosnowski, Images beyond clinical presentation?
www.cardiologyjournal.org
is important to state that the lack of clinical end-
points is the ‘Achilles heel’ of Mao’s study. A lack
of data regarding clinical outcome in ESRD patients
and clinical management guided by the results of
CCTA does not permit the position of CCTA among
non-invasive procedures to be determined.
What is necessary to confirm or reject
the implications of the study?
Noninvasive diagnostic procedures, if they
form a basis of medical management, should under-
go a path of examination similar to that of drugs.
The most obvious method is a randomized study,
in part of which a subject’s noninvasive modality is
examined, and in another part previously used
methods are used. In both arms, a ‘gold standard’
invasive study would be mandatory. Despite the
relatively high accuracy of noninvasive coronary
computed tomography angiography for excluding
significant coronary lesions, evaluating the severi-
ty of plaques (either calcified or non-calcified) is less
straightforward, especially in the presence of high
calcium deposits. An anatomical severity does not
necessarily correspond with the functional sequels,
i.e. acute ischemia or hibernation. For the results
to be valuable, a multi-center study with a greater
number of participants would be necessary. For
CCTA as an alternative method to ICA, cardiac
events (outcome) and management (decision)
should be tested in a random fashion. Of course,
such an attempt in symptomatic persons might pro-
vide an ethical dilemma. However, until answers are
given in properly planned and controlled studies,
CCTA remains an experimental tool that should not
be used routinely, especially in high-risk populations.
Clinical presentation should be considered as more
important than any impressive images.
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